Augmented Therapy Improves Outcome For Pediatric High Risk Acute Lymphocytic Leukemia: Results Of Children’s Oncology Group Trial P9906

BACKGROUND: The augmented BFM regimen improves outcome for children with NCI high acute lymphoblastic leukemia (ALL). Patient age, sex, and presenting white blood cell count (WBC) can be used to identify a subset of approximately 12% of children with B-precursor ALL that had a 5-year continuous comp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bowman, W. Paul, Larsen, Eric L, Devidas, Meenakshi, Linda, Stephen B., Blach, Laurie, Carroll, Andrew J, Carroll, William L, Pullen, D. Jeanette, Shuster, Jonathan, Willman, Cheryl L, Winick, Naomi, Camitta, Bruce M, Hunger, Stephen P, Borowitz, Michael J
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3136564/
https://ncbi.nlm.nih.gov/pubmed/21360654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22944
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge